Delivering Innovation in Self-Care (DISC)

PSI will leverage technology to gain insights as well as excite and support users across India, Nigeria and Uganda in new ways and drive rapid and sustainable increases in self-injection of subcutaneous depo-medroxyprogesterone acetate (DMPA-SC). By leveraging technology, PSI will connect consumers to the information, services and products they want—when and where they want them—at decreased out-of-pocket costs.